{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:13:48Z","timestamp":1786403628158,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T00:00:00Z","timestamp":1414713600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10198-014-0638-9","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T10:35:43Z","timestamp":1414665343000},"page":"927-939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["EQ-5D in skin conditions: an assessment of validity and responsiveness"],"prefix":"10.1007","volume":"16","author":[{"given":"Yaling","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Brazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Longworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,31]]},"reference":[{"key":"638_CR1","volume-title":"NICE Guide to the Methods of Technology Appraisal","author":"NICE","year":"2008","unstructured":"NICE: NICE Guide to the Methods of Technology Appraisal. NICE, London (2008)"},{"key":"638_CR2","volume-title":"NICE Guide to the Methods of Technology Appraisal","author":"NICE","year":"2013","unstructured":"NICE: NICE Guide to the Methods of Technology Appraisal. NICE, London (2013)"},{"issue":"1","key":"638_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks, R.: EuroQol: the current state of play. Health Policy 37(1), 53\u201372 (1996)","journal-title":"Health Policy"},{"issue":"11","key":"638_CR4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan, P.: Modeling valuations for EuroQol health states. Med. Care 35(11), 1095\u20131108 (1997)","journal-title":"Med. Care"},{"issue":"2","key":"638_CR5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier, J., Roberts, J., Deverill, M.: The estimation of a preference-based measure of health from the SF-36. J. Health Econ. 21(2), 271\u2013292 (2002). pii:S0167-6296(01)00130-8 (published online first)","journal-title":"J. Health Econ."},{"issue":"2","key":"638_CR6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005650-200202000-00006","volume":"40","author":"D Feeny","year":"2002","unstructured":"Feeny, D., Furlong, W., Torrance, G.W., et al.: Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med. Care 40(2), 113\u2013128 (2002)","journal-title":"Med. Care"},{"issue":"1","key":"638_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hec.667","volume":"11","author":"J Dowie","year":"2002","unstructured":"Dowie, J.: Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions. Health Econ. 11(1), 1\u20138 (2002)","journal-title":"Health Econ."},{"issue":"10","key":"638_CR8","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman, M., Gudex, C., Lloyd, A., et al.: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res. 20(10), 1727\u20131736 (2011)","journal-title":"Qual. Life Res."},{"issue":"3","key":"638_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/14992020500057566","volume":"44","author":"GR Barton","year":"2005","unstructured":"Barton, G.R., Bankart, J., Davis, A.C.: A comparison of the quality of life of hearing-impaired people as estimated by three different utility measures. Int. J. Audiol. 44(3), 157\u2013163 (2005)","journal-title":"Int. J. Audiol."},{"issue":"9","key":"638_CR10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/hec.866","volume":"13","author":"J Brazier","year":"2004","unstructured":"Brazier, J., Roberts, J., Tsuchiya, A., Busschbach, J.: A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 13(9), 873\u2013884 (2004). doi: 10.1002\/hec.866 . [published Online First: Epub Date]","journal-title":"Health Econ."},{"issue":"12","key":"638_CR11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/hec.787","volume":"12","author":"L Longworth","year":"2003","unstructured":"Longworth, L., Bryan, S.: An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ. 12(12), 1061\u20131067 (2003). doi: 10.1002\/hec.787 . (published online first)","journal-title":"Health Econ."},{"issue":"32","key":"638_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16320","volume":"16","author":"JE Brazier","year":"2012","unstructured":"Brazier, J.E., Rowen, D., Mavranezouli, I., et al.: Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome). Health Technol. Assess. 16(32), 1\u2013114 (2012). doi: 10.3310\/hta16320 . (published online first)","journal-title":"Health Technol. Assess."},{"issue":"3","key":"638_CR13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella, D.F., Tulsky, D.S., Gray, G., et al.: The functional assessment of cancer therapy scale: development and validation of the general measure. J. Clin. Oncol. 11(3), 570\u2013579 (1993)","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"638_CR14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jval.2011.04.006","volume":"14","author":"D Papaioannou","year":"2011","unstructured":"Papaioannou, D., Brazier, J., Parry, G.: How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? Syst. Rev. Value Health 14(6), 907\u2013920 (2011)","journal-title":"Syst. Rev. Value Health"},{"issue":"1","key":"638_CR15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jval.2011.08.002","volume":"15","author":"J Tosh","year":"2011","unstructured":"Tosh, J., Brazier, J., Evans, P., Longworth, L.: A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health 15(1), 118\u2013127 (2011)","journal-title":"Value Health"},{"key":"638_CR16","unstructured":"Brazier, J. E., Connell, J., Papaioannou, D., et al.: Validating generic preference-based measures of health in mental health populations and estimating mapping functions for widely used specific measures. Health Technol. Assess. (In press)"},{"issue":"1","key":"638_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/(SICI)1099-1050(199902)8:1<41::AID-HEC395>3.0.CO;2-#","volume":"8","author":"J Brazier","year":"1999","unstructured":"Brazier, J., Deverill, M.: A checklist for judging preference based measures of health related quality of life: learning from psychometrics. Health Econ. 8(1), 41\u201351 (1999)","journal-title":"Health Econ."},{"issue":"2","key":"638_CR18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2133.1997.tb14895.x","volume":"136","author":"BF O\u2019donnell","year":"1997","unstructured":"O\u2019donnell, B.F., Lawlor, F., Simpson, J., Morgan, M., Greaves, M.W.: The impact of chronic urticaria on the quality of life. Br. J. Dermatol. 136(2), 197\u2013201 (1997)","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"638_CR19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/archderm.134.4.454","volume":"134","author":"RJ Lasek","year":"1998","unstructured":"Lasek, R.J., Chren, M.M.: Acne vulgaris and the quality of life of adult dermatology patients. Arch. Dermatol. 134(4), 454 (1998)","journal-title":"Arch. Dermatol."},{"key":"638_CR20","unstructured":"Group, E. ( http:\/\/www.euroqol.org\/eq-5d-references\/reference-search.html) . Accessed on September 2010"},{"issue":"5","key":"638_CR21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0895-4356(89)90128-5","volume":"42","author":"GH Guyatt","year":"1989","unstructured":"Guyatt, G.H., Deyo, R.A., Charlson, M., Levine, M.N., Mitchell, A.: Responsiveness and validity in health status measurement: a clarification. J. Clin. Epidemiol. 42(5), 403\u2013408 (1989)","journal-title":"J. Clin. Epidemiol."},{"issue":"2 I","key":"638_CR22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1067\/mjd.2000.105507","volume":"43","author":"AFN Klassen","year":"2000","unstructured":"Klassen, A.F.N., Newton, J.N., Mallon, E.: Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J. Am. Acad. Dermatol. 43(2 I), 229\u2013233 (2000)","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"638_CR23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2133.2004.06134.x","volume":"151","author":"PCM Kerkhof Van De","year":"2004","unstructured":"Van De Kerkhof, P.C.M.: The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet\/Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial. Br. J. Dermatol. 151(3), 663\u2013668 (2004)","journal-title":"Br. J. Dermatol."},{"key":"638_CR24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/rheumatology\/kel147","volume":"45","author":"NJ Bansback","year":"2006","unstructured":"Bansback, N.J., Ara, R., Barkham, N., et al.: Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis. Rheumatology 45, 1029\u20131038 (2006)","journal-title":"Rheumatology"},{"issue":"5","key":"638_CR25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1468-3083.2009.03463.x","volume":"24","author":"E Christophers","year":"2010","unstructured":"Christophers, E., JNWN, B., CEM, G., et al.: The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J. Eur. Acad. Dermatol. Venereol. 24(5), 548\u2013554 (2010)","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"12","key":"638_CR26","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1468-3083.2009.03321.x","volume":"23","author":"E Daud\u00e9n","year":"2009","unstructured":"Daud\u00e9n, E., Griffiths, C., Ortonne, J.-P., et al.: Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54\u00a0weeks: the CRYSTEL study. J. Eur. Acad. Dermatol. Venereol. 23(12), 1374\u20131382 (2009)","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"8","key":"638_CR27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1468-3083.2009.03211.x","volume":"23","author":"T Luger","year":"2009","unstructured":"Luger, T., Barker, J., Lambert, J., et al.: Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis. J. Eur. Acad. Dermatol. Venereol. 23(8), 896\u2013904 (2009)","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"3","key":"638_CR28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000237871","volume":"219","author":"K Reich","year":"2009","unstructured":"Reich, K., Segaert, S., Van de Kerkhof, P., et al.: Once-weekly administration of etanercept 50\u00a0mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis. Dermatology 219(3), 239\u2013249 (2009)","journal-title":"Dermatology"},{"issue":"4","key":"638_CR29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1067\/mjd.2002.122755","volume":"47","author":"S Weiss","year":"2002","unstructured":"Weiss, S., Kimball, A., Liewehr, D., Blauvelt, A., Turner, M., Emanuel, E.: Quantifying the harmful effect of psoriasis on health-related quality of life. J. Am. Acad. Dermatol. 47(4), 512\u2013518 (2002)","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"638_CR30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/03009740903468982","volume":"39","author":"V Brodszky","year":"2010","unstructured":"Brodszky, V., P\u00e9ntek, M., B\u00e1lint, P., et al.: Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey. Scand. J. Rheumatol. 39(4), 303\u2013309 (2010)","journal-title":"Scand. J. Rheumatol."},{"key":"638_CR31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7525-4-71","volume":"4","author":"R Shikiar","year":"2006","unstructured":"Shikiar, R., Willian, M., Okun, M., Thompson, C., Revicki, D.: The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual. Life Outcomes 4, 71 (2006)","journal-title":"Health Qual. Life Outcomes"},{"issue":"3","key":"638_CR32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.2007.08236.x","volume":"158","author":"D Revicki","year":"2008","unstructured":"Revicki, D., Willian, M.K., Saurat, J.-H., et al.: Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Br. J. Dermatol. 158(3), 549\u2013557 (2008)","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"638_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/09546630601121060","volume":"18","author":"R Shikiar","year":"2007","unstructured":"Shikiar, R., Heffernan, M., Langley, R., Willian, M., Okun, M., Revicki, D.: Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a Phase II randomized controlled trial. J. Dermatol. Treat. 18(1), 25\u201331 (2007)","journal-title":"J. Dermatol. Treat."},{"issue":"3","key":"638_CR34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/tcrm.2006.2.3.325","volume":"2","author":"SCR Weiss","year":"2006","unstructured":"Weiss, S.C.R., Rehmus, W., Kimball, A.: An assessment of the cost-utility of therapy for psoriasis. Ther. Clin. Risk Manag. 2(3), 325\u2013328 (2006)","journal-title":"Ther. Clin. Risk Manag."},{"issue":"3","key":"638_CR35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","volume":"90","author":"L Matusiak","year":"2010","unstructured":"Matusiak, L., Bieniek, A., Szepietowski, J.C.: Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol 90(3), 264\u2013268 (2010)","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"638_CR36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2133.2009.09099.x","volume":"161","author":"C Moberg","year":"2009","unstructured":"Moberg, C., Alderling, M., Meding, B.: Hand eczema and quality of life: a population-based study. Br. J. Dermatol. 161(2), 397\u2013403 (2009)","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"638_CR37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1023\/A:1008992006845","volume":"8","author":"SJ Walters","year":"1999","unstructured":"Walters, S.J., Morrell, C.J., Dixon, S.: Measuring health-related quality of life in patients with venous leg ulcers. Qual. Life Res. 8(4), 327\u2013336 (1999)","journal-title":"Qual. Life Res."},{"issue":"9","key":"638_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18090","volume":"18","author":"L Longworth","year":"2014","unstructured":"Longworth, L., Yang, Y., Young, T., et al.: Use of generic and condition-specific measures of health related quality of life in NICE decision-making. Health Technol. Assess. 18(9), 1\u2013224 (2014)","journal-title":"Health Technol. Assess."},{"issue":"8","key":"638_CR39","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jval.2013.10.003","volume":"16","author":"P Swinburn","year":"2013","unstructured":"Swinburn, P., Lloyd, A., Boye, K.S., Edson-Heredia, E., Bowman, L., Janssen, B.: Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK. Value Health 16(8), 1156\u20131162 (2013)","journal-title":"Value Health"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-014-0638-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10198-014-0638-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-014-0638-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:52:30Z","timestamp":1553640750000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10198-014-0638-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,31]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["638"],"URL":"https:\/\/doi.org\/10.1007\/s10198-014-0638-9","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,31]]}}}